Financials

News Discussions Technicals Seasonals

IMP_A_SDB fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Implantica AG engages in the provision of effective care for serious health conditions and improving patient quality of life by bringing advanced technology into the body. Its product RefluxStop, is a passive CE-marked implant for prevention of gastroesophageal reflux. The company was founded by Peter Forsell in 2015 and is headquartered in Vaduz, Liechtenstein.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

IMP_A_SDB does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company